BMO Capital Maintains Outperform on Nuvalent, Raises Price Target to $102
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst Etzer Darout has maintained an Outperform rating on Nuvalent (NASDAQ:NUVL) and increased the price target from $93 to $102.
February 28, 2024 | 2:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BMO Capital has reaffirmed its Outperform rating on Nuvalent and raised its price target from $93 to $102.
The upgrade in the price target by BMO Capital indicates a strong confidence in Nuvalent's future performance. This positive analyst action can lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100